Cargando…
Price subsidies increase the use of private sector ACTs: evidence from a systematic review
Background Although artemisinin combination therapies (ACTs) are the recommended first-line treatment for uncomplicated malaria in most endemic countries, they have been prohibitively expensive in the retail sector where many suspected malaria cases purchase treatment. ACT subsidies seek to stimulat...
Autores principales: | Morris, Alexandra, Ward, Abigail, Moonen, Bruno, Sabot, Oliver, Cohen, Justin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353896/ https://www.ncbi.nlm.nih.gov/pubmed/24633915 http://dx.doi.org/10.1093/heapol/czu013 |
Ejemplares similares
-
Do Price Subsidies on Artemisinin Combination Therapy for Malaria Increase Household Use?: Evidence from a Repeated Cross-Sectional Study in Remote Regions of Tanzania
por: Cohen, Jessica L., et al.
Publicado: (2013) -
Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed through Private Drug Shops in Rural Tanzania
por: Sabot, Oliver J., et al.
Publicado: (2009) -
Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study
por: Talisuna, Ambrose O, et al.
Publicado: (2012) -
The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy
por: O’Meara, Wendy Prudhomme, et al.
Publicado: (2013) -
Overcoming the affordability barrier for effective and high quality life saving malaria medicines in the private sector in rural Uganda: the Consortium for ACT Private Sector Subsidy (CAPSS) pilot study
por: Talisuna, Ambrose O, et al.
Publicado: (2012)